Marek Borský

855 total citations
26 papers, 556 citations indexed

About

Marek Borský is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Marek Borský has authored 26 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 9 papers in Molecular Biology and 9 papers in Hematology. Recurrent topics in Marek Borský's work include Chronic Lymphocytic Leukemia Research (16 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and Acute Myeloid Leukemia Research (5 papers). Marek Borský is often cited by papers focused on Chronic Lymphocytic Leukemia Research (16 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and Acute Myeloid Leukemia Research (5 papers). Marek Borský collaborates with scholars based in Czechia, Slovakia and Austria. Marek Borský's co-authors include Libor Kozák, Jiřı́ Mayer, Michael Doubek, Šárka Pospı́šilová, Yvona Brychtová, Marek Mráz, Martin Trbušek, Kateřina Amruz Černá, Václav Šeda and Karla Plevová and has published in prestigious journals such as Blood, Clinical Cancer Research and British Journal of Haematology.

In The Last Decade

Marek Borský

26 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek Borský Czechia 13 216 188 138 120 111 26 556
Kairen Kukalizch United Kingdom 7 83 0.4× 48 0.3× 90 0.7× 85 0.7× 193 1.7× 9 508
Kristian Reckzeh Denmark 12 205 0.9× 72 0.4× 215 1.6× 98 0.8× 16 0.1× 22 423
Sai Juan Chen China 12 550 2.5× 64 0.3× 327 2.4× 58 0.5× 30 0.3× 13 766
Elena Cesaro Italy 15 425 2.0× 46 0.2× 60 0.4× 67 0.6× 31 0.3× 27 570
Andrzej Jakubowiak United States 15 467 2.2× 102 0.5× 430 3.1× 64 0.5× 55 0.5× 54 723
Olga Haus Poland 14 236 1.1× 65 0.3× 144 1.0× 39 0.3× 53 0.5× 85 528
Marisa Pautasso Italy 12 264 1.2× 187 1.0× 262 1.9× 62 0.5× 69 0.6× 35 584
Patrick Morice France 11 100 0.5× 211 1.1× 238 1.7× 51 0.4× 75 0.7× 20 394
Heather Glaser United States 9 512 2.4× 79 0.4× 167 1.2× 75 0.6× 37 0.3× 9 636
Marie‐Laure Island France 12 130 0.6× 148 0.8× 203 1.5× 80 0.7× 3 0.0× 22 462

Countries citing papers authored by Marek Borský

Since Specialization
Citations

This map shows the geographic impact of Marek Borský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Borský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Borský more than expected).

Fields of papers citing papers by Marek Borský

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Borský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Borský. The network helps show where Marek Borský may publish in the future.

Co-authorship network of co-authors of Marek Borský

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Borský. A scholar is included among the top collaborators of Marek Borský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Borský. Marek Borský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeman, David, et al.. (2023). Isoelectric focusing followed by affinity immunoblotting to detect monoclonal free light chains in monoclonal gammopathies: Comparison with immunofixation electrophoresis and free light chain ratio. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 61(4). 291–302. 1 indexed citations
2.
Pavlová, Šárka, Beatríz González, Jana Kotašková, et al.. (2022). Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A gene. Epigenetics. 17(12). 1628–1635. 3 indexed citations
3.
Khirsariya, Prashant, Marek Borský, Jan Verner, et al.. (2019). Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells. Haematologica. 104(12). 2443–2455. 22 indexed citations
4.
Pavlasová, Gabriela Mladonická, Marek Borský, Veronika Svobodová, et al.. (2018). Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels. Leukemia. 32(9). 2028–2031. 20 indexed citations
5.
Pavlasová, Gabriela Mladonická, Marek Borský, Václav Šeda, et al.. (2016). Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis. Blood. 128(12). 1609–1613. 83 indexed citations
6.
Veselý, Pavel, Alexandra Oltová, Marek Borský, et al.. (2016). Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells. Oncotarget. 7(38). 62091–62106. 17 indexed citations
7.
Borský, Marek, Veronika Némethová, Filip Rázga, et al.. (2016). Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects. Oncotarget. 7(22). 33016–33024. 29 indexed citations
8.
Janovská, Pavlína, Karla Plevová, Markéta Kaucká, et al.. (2015). Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 22(2). 459–469. 52 indexed citations
9.
Borský, Marek, David Potěšil, Veronika Navrkalová, et al.. (2014). Distinct in vitro sensitivity of p53-mutated and ATM-mutated chronic lymphocytic leukemia cells to ofatumumab and rituximab. Experimental Hematology. 42(10). 867–874.e1. 10 indexed citations
10.
Mráz, Marek, Kateřina Staňo Kozubík, Karla Plevová, et al.. (2013). The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus. Leukemia Research. 37(7). 802–808. 11 indexed citations
11.
Loja, Tomáš, et al.. (2013). Expression of the stem cell marker nestin in leukemia cells. 1 indexed citations
12.
Dvořáková, Dana, Zdeněk Ráčil, Marek Borský, et al.. (2012). Clonal heterogeneity in patients with cytogenetically normal acute myeloid leukemia withNPM1mutations. Leukemia & lymphoma. 54(5). 1056–1060. 2 indexed citations
13.
Mayer, Jiřı́, et al.. (2010). Increasing hematopoietic microchimerism is a reliable indicator of incipient AML relapse. International Journal of Laboratory Hematology. 33(1). 57–66. 16 indexed citations
14.
15.
Kozubík, Kateřina Staňo, Jitka Malčíková, Boris Tichý, et al.. (2009). Inactivation of p53 and amplification of MYCN gene in a terminal lymphoblastic relapse in a chronic lymphocytic leukemia patient. Cancer Genetics and Cytogenetics. 189(1). 53–58. 5 indexed citations
16.
Čejková, Soňa, David Potěšil, Jana Šmardová, et al.. (2008). Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine. European Journal Of Haematology. 82(2). 133–142. 10 indexed citations
17.
Borský, Marek, et al.. (2005). Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease. Molecular Genetics and Metabolism. 86(1-2). 277–285. 107 indexed citations
18.
Maláska, Jan, et al.. (2004). Telomerase as a diagnostic and predictive marker in colorectal carcinoma.. PubMed. 51(2). 90–6. 22 indexed citations
19.
Fajkus, Jiřı́, et al.. (2003). Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells.. PubMed. 23(2B). 1605–12. 19 indexed citations
20.
Borský, Marek & F Gutzwiller. (1994). [Does insurance status have an effect on frequency of appendectomies?].. PubMed. 124(37). 1619–25. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kairen Kukalizch Breakdown of academic impact, for papers by Kristian Reckzeh Breakdown of academic impact, for papers by Sai Juan Chen Breakdown of academic impact, for papers by Elena Cesaro Breakdown of academic impact, for papers by Andrzej Jakubowiak Breakdown of academic impact, for papers by Olga Haus Breakdown of academic impact, for papers by Marisa Pautasso Breakdown of academic impact, for papers by Patrick Morice Breakdown of academic impact, for papers by Heather Glaser Breakdown of academic impact, for papers by Marie‐Laure Island
Rankless by CCL
2026